In summary, we successfully constructed transferrin-modified and Pep63-loaded PA-liposomes and found that Tf-Pep63-Lip were effective Aβ-targeting and well-tolerated therapeutic agents for combination therapy in early AD mice. Here, TF is linked to Alzheimer disease.